Literature DB >> 25794062

Lung nodule detection by microdose CT versus chest radiography (standard and dual-energy subtracted).

Lukas Ebner1, Yanik Bütikofer, Daniel Ott, Adrian Huber, Julia Landau, Justus E Roos, Johannes T Heverhagen, Andreas Christe.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the feasibility of microdose CT using a comparable dose as for conventional chest radiographs in two planes including dual-energy subtraction for lung nodule assessment.
MATERIALS AND METHODS: We investigated 65 chest phantoms with 141 lung nodules, using an anthropomorphic chest phantom with artificial lung nodules. Microdose CT parameters were 80 kV and 6 mAs, with pitch of 2.2. Iterative reconstruction algorithms and an integrated circuit detector system (Stellar, Siemens Healthcare) were applied for maximum dose reduction. Maximum intensity projections (MIPs) were reconstructed. Chest radiographs were acquired in two projections with bone suppression. Four blinded radiologists interpreted the images in random order.
RESULTS: A soft-tissue CT kernel (I30f) delivered better sensitivities in a pilot study than a hard kernel (I70f), with respective mean (SD) sensitivities of 91.1%±2.2% versus 85.6%±5.6% (p=0.041). Nodule size was measured accurately for all kernels. Mean clustered nodule sensitivity with chest radiography was 45.7%±8.1% (with bone suppression, 46.1%±8%; p=0.94); for microdose CT, nodule sensitivity was 83.6%±9% without MIP (with additional MIP, 92.5%±6%; p<10(-3)). Individual sensitivities of microdose CT for readers 1, 2, 3, and 4 were 84.3%, 90.7%, 68.6%, and 45.0%, respectively. Sensitivities with chest radiography for readers 1, 2, 3, and 4 were 42.9%, 58.6%, 36.4%, and 90.7%, respectively. In the per-phantom analysis, respective sensitivities of microdose CT versus chest radiography were 96.2% and 75% (p<10(-6)). The effective dose for chest radiography including dual-energy subtraction was 0.242 mSv; for microdose CT, the applied dose was 0.1323 mSv.
CONCLUSION: Microdose CT is better than the combination of chest radiography and dual-energy subtraction for the detection of solid nodules between 5 and 12 mm at a lower dose level of 0.13 mSv. Soft-tissue kernels allow better sensitivities. These preliminary results indicate that microdose CT has the potential to replace conventional chest radiography for lung nodule detection.

Entities:  

Keywords:  CT dose reduction; chest CT dose; lung lesion detection; microdose CT imaging

Mesh:

Year:  2015        PMID: 25794062     DOI: 10.2214/AJR.14.12921

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging.

Authors:  Adrian Huber; Julia Landau; Lukas Ebner; Yanik Bütikofer; Lars Leidolt; Barbara Brela; Michelle May; Johannes Heverhagen; Andreas Christe
Journal:  Eur Radiol       Date:  2016-01-26       Impact factor: 5.315

2.  The additional value of the lateral chest radiograph for the detection of small pulmonary nodules-a ROC analysis.

Authors:  Robin Alexander Kluthke; Ralph Kickuth; Paul Martin Bansmann; Carolin Tüshaus; Stephan Adams; Dieter Liermann; Johannes Kirchner
Journal:  Br J Radiol       Date:  2016-09-26       Impact factor: 3.039

3.  Guideline of guidelines: Muscle-invasive bladder cancer.

Authors:  Nicolas Pavlos Omorphos; John Carlo Pansaon Piedad; Nikhil Vasdev
Journal:  Turk J Urol       Date:  2020-09-21

4.  Performance of an AI based CAD system in solid lung nodule detection on chest phantom radiographs compared to radiology residents and fellow radiologists.

Authors:  Alan A Peters; Amanda Decasper; Jaro Munz; Jeremias Klaus; Laura I Loebelenz; Maximilian Korbinian Michael Hoffner; Cynthia Hourscht; Johannes T Heverhagen; Andreas Christe; Lukas Ebner
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 3.005

5.  Diagnostic validation of a deep learning nodule detection algorithm in low-dose chest CT: determination of optimized dose thresholds in a virtual screening scenario.

Authors:  Alan A Peters; Adrian T Huber; Verena C Obmann; Johannes T Heverhagen; Andreas Christe; Lukas Ebner
Journal:  Eur Radiol       Date:  2022-01-21       Impact factor: 5.315

6.  A novel ultrafast-low-dose computed tomography protocol allows concomitant coronary artery evaluation and lung cancer screening.

Authors:  Carlo Gaudio; Gennaro Petriello; Francesco Pelliccia; Alessandra Tanzilli; Alberto Bandiera; Gaetano Tanzilli; Francesco Barillà; Vincenzo Paravati; Massimo Pellegrini; Enrico Mangieri; Paolo Barillari
Journal:  BMC Cardiovasc Disord       Date:  2018-05-08       Impact factor: 2.298

7.  Dual-source computed tomography of the lung with spectral shaping and advanced iterative reconstruction: potential for maximum radiation dose reduction.

Authors:  Matthias Wetzl; Matthias S May; Daniel Weinmann; Matthias Hammon; Christoph Treutlein; Martin Zeilinger; Alexander Kiefer; Regina Trollmann; Joachim Woelfle; Michael Uder; Oliver Rompel
Journal:  Pediatr Radiol       Date:  2020-06-17

8.  OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose CT (OPTIMACT)-a randomised controlled trial chest X-ray or ultra-low-dose CT at the ED: design and rationale.

Authors:  Inge A H van den Berk; Maadrika M N P Kanglie; Tjitske S R van Engelen; Shandra Bipat; Marcel G W Dijkgraaf; Patrick M M Bossuyt; Wouter de Monyé; Jan M Prins; Jaap Stoker
Journal:  Diagn Progn Res       Date:  2018-08-08

9.  OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose chest CT (OPTIMACT) trial-statistical analysis plan.

Authors:  Maadrika M N P Kanglie; Shandra Bipat; Inge A H van den Berk; Tjitske S R van Engelen; Marcel G W Dijkgraaf; Jan M Prins; Jaap Stoker; Patrick M M Bossuyt
Journal:  Trials       Date:  2020-05-14       Impact factor: 2.279

10.  Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer.

Authors:  Sundeep Agrawal; Naomi B Haas; Mohammadhadi Bagheri; Brian R Lane; Jonathan Coleman; Hans Hammers; Gennady Bratslavsky; Cynthia Chauhan; Lauren Kim; Venkatesh P Krishnasamy; Jamie Marko; Virginia Ellen Maher; Amna Ibrahim; Frank Cross; Ke Liu; Julia A Beaver; Richard Pazdur; Gideon M Blumenthal; Harpreet Singh; Elizabeth R Plimack; Toni K Choueiri; Robert Uzzo; Andrea B Apolo
Journal:  JAMA Oncol       Date:  2020-01-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.